A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome.
endocrine disorders
non-alcoholic steatohepatitis (nash)
nonalcoholic fatty liver disease (nafld)
polycystic ovary syndrome (pcos)
women of reproductive age
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
04
08
2022
accepted:
04
10
2022
entrez:
16
11
2022
pubmed:
17
11
2022
medline:
17
11
2022
Statut:
epublish
Résumé
Polycystic ovary syndrome (PCOS) is a complex hormonal disorder associated with complications throughout various body organs. Previous studies have shown evidence of liver disease in some women with PCOS. In this study, we attempted to explore the risk of non-alcoholic fatty liver disease (NAFLD) in PCOS women and the specific factors involved in its development. We searched PubMed, PubMed Central, Medline, and ScienceDirect for articles related to the topic, screened those articles according to our inclusion/exclusion criteria, and conducted a thorough quality check using various quality appraisal tools to select articles relevant to our research. The process was conducted according to Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) Checklist 2020. We selected 11 high-quality observational studies for our review. Studies from various countries were included, and all studies demonstrated an increased prevalence of NAFLD in PCOS patients compared to healthy controls. Although insulin resistance, obesity, and increased androgens contribute to the increase in the risk of NAFLD in these patients, hyperandrogenism was the most influential risk factor in four of these studies. Two studies explored the degree of NAFLD in these patients using transient elastography (TE). They concluded that PCOS was significantly associated with hepatic steatosis (HS) rather than hepatic fibrosis in most patients. PCOS patients have an increased risk of developing NAFLD, particularly HS, and hyperandrogenism seems to be the main determinant. Therefore, effort should be put into screening and monitoring these patients to manage the disease. TE may be a useful method for monitoring the natural history of NAFLD in these patients, which requires further exploration.
Identifiants
pubmed: 36381833
doi: 10.7759/cureus.29928
pmc: PMC9635930
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e29928Informations de copyright
Copyright © 2022, Shahbaz et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sci Rep. 2021 Mar 29;11(1):7085
pubmed: 33782517
Liver Int. 2020 Feb;40(2):355-359
pubmed: 31627243
PLoS One. 2017 Nov 21;12(11):e0186136
pubmed: 29161258
Hormones (Athens). 2014 Oct-Dec;13(4):519-31
pubmed: 25402369
Aliment Pharmacol Ther. 2011 Apr;33(7):801-14
pubmed: 21251033
Clin Gastroenterol Hepatol. 2007 Apr;5(4):496-501
pubmed: 17287148
Fertil Steril. 2013 Dec;100(6):1745-51
pubmed: 24034940
Reprod Health. 2018 May 10;15(1):77
pubmed: 29747678
Aliment Pharmacol Ther. 2017 Jun;45(11):1403-1412
pubmed: 28370150
Hum Reprod. 2010 Jan;25(1):212-20
pubmed: 19887498
Dan Med J. 2016 Apr;63(4):
pubmed: 27034186
J Clin Endocrinol Metab. 2012 Oct;97(10):3709-16
pubmed: 22837189
World J Gastroenterol. 2014 Jul 14;20(26):8351-63
pubmed: 25024594
World J Gastroenterol. 2020 Nov 28;26(44):7046-7060
pubmed: 33311949
PLoS Med. 2018 Mar 28;15(3):e1002542
pubmed: 29590099
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Indian J Med Res. 2020 Apr;151(4):333-341
pubmed: 32461397
Hormones (Athens). 2009 Jul-Sep;8(3):199-206
pubmed: 19671519
Ann Hepatol. 2020 May - Jun;19(3):251-257
pubmed: 32111488
Hum Reprod. 2016 Jun;31(6):1347-53
pubmed: 27076501
Arq Gastroenterol. 2015 Apr-Jun;52(2):117-23
pubmed: 26039829
BMJ Open Gastroenterol. 2020 Aug;7(1):
pubmed: 32784205
Endokrynol Pol. 2014;65(6):416-21
pubmed: 25554608
Ultrasound Obstet Gynecol. 2012 Mar;39(3):341-7
pubmed: 21898634
Arch Endocrinol Metab. 2020 May-Jun;64(3):235-242
pubmed: 32555989
Int J Womens Health. 2015 Jul 31;7:745-63
pubmed: 26261426